Your account is not claimed yet. You can sign up with ORCID to claim your account.

Joost C M Meijers (David J Clark, J C M Meijers)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 18

Top Venues

Journal of thrombosis and haemostasis : JTH

Blood

Research and practice in thrombosis and haemostasis

Thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Joost C M Meijers, Johanneke van der Harst, Pauline F Marx, Peyman Sahbaie, Joost C M Meijers, John Morser
Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior. Thrombosis and haemostasis (2023)
Nicola J Mutch, Sam Walters, Elizabeth E Gardiner, Owen J T McCarty, Simon F De Meyer, Verena Schroeder, Joost C M Meijers
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH 20 (6) (2022)
Awital Bar Barroeta, J Arnoud Marquart, Kamran Bakhtiari, Alexander Benjamin Meijer, Rolf T Urbanus, Joost C M Meijers
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen. Journal of thrombosis and haemostasis : JTH 20 (11) (2022)
Marc V A van Moorsel, Geke C Poolen, Cornelis A Koekman, Sandra Verhoef, Steven de Maat, Arjan Barendrecht, Nadine D van Kleef, Joost C M Meijers, Raymond M Schiffelers, Coen Maas, Rolf T Urbanus
VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Herm Jan M Brinkman, Frauke Swieringa, Marleen Zuurveld, Alicia Veninga, Sanne L N Brouns, Johan W M Heemskerk, Joost C M Meijers
Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro. Research and practice in thrombosis and haemostasis 6 (3) (2022)
Herm Jan M Brinkman, Marleen Zuurveld, Joost C M Meijers
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Anja Maag, Nienke van Rein, Tim J Schuijt, Wil F Kopatz, Danielle Kruijswijk, Stella Thomassen, Tilman M Hackeng, Rodney M Camire, Tom van der Poll, Joost C M Meijers, Mettine H A Bos, Cornelis van 't Veer
Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa. Journal of thrombosis and haemostasis : JTH (2021)
Joost C M Meijers, Saskia Middeldorp
An anticoagulant that does not cause bleeding - an abrupt stop on the road to the Holy Grail. Journal of thrombosis and haemostasis : JTH 17 (12) (2020)
Alvin H Schmaier, Jonas Emsley, Edward P Feener, David Gailani, José W P Govers-Riemslag, Allen Phillip Kaplan, Coen Maas, James H Morrissey, Thomas Renné, Johannes J Sidelmann, Joost C M Meijers
Nomenclature of factor XI and the contact system. Journal of thrombosis and haemostasis : JTH 17 (12) (2019)
Awital Bar Barroeta, Josse van Galen, Ingrid Stroo, J Arnoud Marquart, Alexander Benjamin Meijer, Joost C M Meijers
Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa. Journal of thrombosis and haemostasis : JTH 17 (12) (2019)
Joost C M Meijers
Prochemerin processing by factor XIa. Blood 131 (3) (2019)
Kamran Bakhtiari, Joost C M Meijers
In vitro evaluation of factor IX as novel treatment for factor XI deficiency. Blood 134 (6) (2019)
Joost C M Meijers, Alvin H Schmaier
Contact ignition by single-chain XIIa. Blood 129 (11) (2018)
H Wan, Y Wang, J Ai, S Brathwaite, H Ni, R L Macdonald, E M Hol, Joost C M Meijers, M D I Vergouwen
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage. Journal of thrombosis and haemostasis : JTH 16 (7) (2018)
J W R Sins, M Schimmel, B M Luken, E Nur, S S Zeerleder, C F J van Tuijn, D P M Brandjes, W F Kopatz, Rolf T Urbanus, Joost C M Meijers, B J Biemond, K Fijnvandraat
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state. Journal of thrombosis and haemostasis : JTH 15 (7) (2017)
C J Majoor, M M S Sneeboer, A de Kievit, Joost C M Meijers, T van der Poll, R Lutter, E H Bel, P W Kamphuisen
The influence of corticosteroids on hemostasis in healthy subjects. Journal of thrombosis and haemostasis : JTH 14 (4) (2016)
T Plug, Joost C M Meijers
Structure-function relationships in thrombin-activatable fibrinolysis inhibitor. Journal of thrombosis and haemostasis : JTH 14 (4) (2016)
Marisa L R Cunha, Kamran Bakhtiari, Jorge Peter, J Arnoud Marquart, Joost C M Meijers, Saskia Middeldorp
A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function. Blood 125 (11) (2015)

Joost C M Meijers.css-eqlu8i{font-size:small;padding-left:4px;} (David J Clark, J C M Meijers)

Publication Activity (10 Years)

Top Topics

Top Venues

Joost C M Meijers (David J Clark, J C M Meijers)